Belladonna Therapeutic Serum
A calibrated belladonna-derived serum for ophthalmic and cardiac research protocols. Controlled-access product.
Product Overview
Belladonna Therapeutic Serum is a calibrated belladonna-derived serum formulated for ophthalmic and cardiac research protocols. It is a Restricted-grade, Restricted-hazard, controlled-access product on Tier-3 clearance, made to order.
Formulation & Mechanism
The serum standardizes an atropine–scopolamine fraction from the facility's Atropa stock to a therapeutic-window concentration, formulated for controlled dosing in animal and tissue models. Each made-to-order lot is titrated to the protocol on file and released with a potency certificate and a handling addendum.
Applications & Clientele
Research groups use it in pupil-dilation and cardiac-rhythm studies where a precisely known anticholinergic dose is required. Distribution is gated to institutions with an approved protocol; the same molecule's therapeutic and toxic doses are close enough that the product ships with a hard-stop dosing table.
Handling & Safety
Belladonna Therapeutic Serum is a restricted-hazard material. Access is limited to trained, cleared personnel; handling follows the Toxin Handling controlled procedure, and the product ships with a lot-specific handling addendum. Storage, use, and disposal must be documented against the client's institutional licence.
Provenance & Licensing
Produced under full containment at Sector-7 and gated to Tier-3 clearance. Distribution is entered in the controlled ledger against a named, licensed institution and responsible custodian; re-propagation or resale rights are withheld and, for toxin lines, a disposal return is mandatory.
Catalogue revenue flows to the Commercial Directorate and underwrites the facility's restricted research programs. See Finance →